CSL opens cell-based influenza vaccine and antivenom manufacturing facility in Melbourne

CSL opens cell-based influenza vaccine and antivenom manufacturing facility in Melbourne

December 6, 2025 | Saturday | News

New facility will replace the…

Continue Reading